(MENAFNEditorial) iCrowdNewswire - Oct 15, 2018
This report studies the Oncolytic Virus Therapy market status and outlook of global, from angles of players, regions, product types and end industries; this report analyzes the top players in global market, and splits the Oncolytic Virus Therapy market by product type and application/end industries.
Request Sample Copy of Report @ https://www.researchtrades.com/request-sample/1537134
The global Oncolytic Virus Therapy market was XX million US$ in 2017 and is expected to XX million US$ by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Oncolytic Virus Therapy in these regions, from 2013 to 2025 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia and Vietnam))
South America (Brazil etc.)
Middle East and Africa (North Africa and GCC Countries)
The major companies in this report including
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
By the product type, the market is primarily split into
Type I
Type II
By the end users/application, this report covers the following segments
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others
Request for discount @ https://www.researchtrades.com/discount/1537134
Table of Contents
1 Oncolytic Virus Therapy Market Overview
1.1 Oncolytic Virus Therapy Product Overview
1.2 Oncolytic Virus Therapy Market Segment by Type
1.2.1 Type I
1.2.2 Type II
1.3 Global Oncolytic Virus Therapy Market Size by Type
1.3.1 Global Oncolytic Virus Therapy Sales and Growth by Type
1.3.2 Global Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
1.3.3 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2013-2018)
1.3.4 Global Oncolytic Virus Therapy Price by Type (2013-2018)
1.4 North America Oncolytic Virus Therapy by Type
1.5 Europe Oncolytic Virus Therapy by Type
1.6 Asia-Pacific Oncolytic Virus Therapy by Type
1.7 South America Oncolytic Virus Therapy by Type
1.8 Middle East and Africa Oncolytic Virus Therapy by Type
2 Global Oncolytic Virus Therapy Market Competition by Company
2.1 Global Oncolytic Virus Therapy Sales and Market Share by Company (2013-2018)
2.2 Global Oncolytic Virus Therapy Revenue and Share by Company (2013-2018)
2.3 Global Oncolytic Virus Therapy Price by Company (2013-2018)
2.4 Global Top Players Oncolytic Virus Therapy Manufacturing Base Distribution, Sales Area, Product Types
2.5 Oncolytic Virus Therapy Market Competitive Situation and Trends
2.5.1 Oncolytic Virus Therapy Market Concentration Rate
2.5.2 Global Oncolytic Virus Therapy Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
Browse Full Report With TOC @ https://www.researchtrades.com/report/oncolytic-virus-therapy-market-report-by-company-regions-types-and-applications-global-status-and-forecast-to-2025/1537134
3 Oncolytic Virus Therapy Company Profiles and Sales Data
3.1 Amgen
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.1.3 Amgen Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Oncolytics Biotech
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.2.3 Oncolytics Biotech Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 Viralytics
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.3.3 Viralytics Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Transgene SA
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.4.3 Transgene SA Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Oncolys BioPharma
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.5.3 Oncolys BioPharma Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Targovax
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.6.3 Targovax Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 PsiOxus Therapeutics
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 SillaJen Biotherapeutics
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 Sorrento Therapeutics
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 Lokon Pharma
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Oncolytic Virus Therapy Product Category, Application and Specification
3.10.3 Lokon Pharma Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
3.11 Genelux Corporation
3.12 Vyriad
3.13 TILT Biotherapeutics
3.14 Cold Genesys
4 Oncolytic Virus Therapy Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Oncolytic Virus Therapy Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Oncolytic Virus Therapy Sales and Revenue by Regions
4.2.1 Global Oncolytic Virus Therapy Sales and Market Share by Regions (2013-2018)
4.2.2 Global Oncolytic Virus Therapy Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Oncolytic Virus Therapy Sales, Revenue, Price and Gross Margin
4.7.1 North Africa
4.7.2 GCC Countries
…
Contact Information:
Email: [email protected]
Call us: +1 6269994607 / +91 7507349866
Skype ID: researchtradescon
Web: www.researchtrades.com
MENAFN1510201800703403ID1097571130
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.